Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents

American Heart Journal

Volumn 163, Issue 5, 2012, Pages

  Billinger, Michael ^a   Räber, Lorenz ^a   Hitz, Sarah ^a   Stefanini, Giulio G ^a   Pilgrim, Thomas ^a   Stettler, Christoph ^a   Zanchin, Thomas ^a   Pulver, Cedric ^a   Pfäffli, Nico ^a   Eberli, Franz ^b   Meier, Bernhard ^a   Kalesan, Bindu ^a,c   Jüni, Peter ^a,c   Windecker, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REVASCULARIZATION;

EID: 84861328727     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.02.014     Document Type: Article

References (25)

1. C. Stettler, S. Wandel, and S. Allemann Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948 (Pubitemid 47393576)
2. C. Stettler, S. Allemann, and S. Wandel Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis BMJ 337 2008 a1331
3. L. Raber, L. Wohlwend, and M. Wigger Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial Circulation 123 2011 2819 2828
4. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662 (Pubitemid 41175673)
5. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
6. J.R. Timmer, J.P. Ottervanger, and M.J. de Boer Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial Arch Intern Med 167 2007 1353 1359 (Pubitemid 47052432)
7. L. Wallentin, B. Lagerqvist, and S. Husted Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease Lancet 356 2000 9 16 (Pubitemid 30416988)
8. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887 (Pubitemid 32564900)
9. A. Norhammar, K. Malmberg, and E. Diderholm Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization J Am Coll Cardiol 43 2004 585 591 (Pubitemid 38229530)
10. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization ofthe European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
11. R.L. Frye, P. August, and M.M. Brooks A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
12. M. Anselmino, K. Malmberg, and J. Ohrvik Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart Eur J Cardiovasc Prev Rehabil 15 2008 216 223 (Pubitemid 351507656)
13. W.B. Kannel, and R.D. Abbott Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study N Engl J Med 311 1984 1144 1147 (Pubitemid 14012581)
14. R.W. Nesto, R.T. Phillips, and K.G. Kett Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy Ann Intern Med 108 1988 170 175 (Pubitemid 18081187)
15. H.S. Cabin, and W.C. Roberts Quantitative comparison of extent of coronary narrowing and size of healed myocardial infarct in 33 necropsy patients with clinically recognized and in 28 with clinically unrecognized ("silent") previous acute myocardial infarction Am J Cardiol 50 1982 677 681 (Pubitemid 12028285)
16. J.K. Kahn, J.C. Sisson, and A.I. Vinik QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy J Clin Endocrinol Metab 64 1987 751 754 (Pubitemid 17044543)
17. S. Elezi, A. Kastrati, and J. Pache Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement J Am Coll Cardiol 32 1998 1866 1873 (Pubitemid 29010448)
18. A. Abizaid, R. Kornowski, and G.S. Mintz The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation J Am Coll Cardiol 32 1998 584 589 (Pubitemid 28435240)
19. J. Schofer, M. Schluter, and T. Rau Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study J Am Coll Cardiol 35 2000 1554 1559 (Pubitemid 30307500)
20. E. Van Belle, M. Perie, and D. Braune Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients J Am Coll Cardiol 40 2002 410 417 (Pubitemid 34833153)
21. C. Spaulding, J. Daemen, and E. Boersma A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 989 997 (Pubitemid 46376799)
22. R. Kornowski, G.S. Mintz, and K.M. Kent Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study Circulation 95 1997 1366 1369 (Pubitemid 27142791)
23. R. Iijima, G. Ndrepepa, and J. Mehilli Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era Am Heart J 154 2007 688 693 (Pubitemid 47440084)
24. J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678 (Pubitemid 46281313)
25. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)